Can Minnesota play a key role in health care's future? The Medicare chief for Obama and the retired General Mills executive sure think so.
Health Care + Med Tech
The brand-new health care investment firm closed its first fund with $115 million and used it to invest in three companies, including local insurance startup Bright Health.
The Gonda Building was in dire need of space to accommodate growing patient traffic to its hometown campus, Mayo Clinic medical professionals said.
The new capital will allow the Brooklyn Park heart therapies maker to hire up to ten new workers, expand into a larger headquarters, and fund new rounds of further testing of its AltaValve device.
The hearing aid maker’s new Livio AI product, the “world’s first multi-use hearing aid,” features improved sound elements and 3D motion sensors for health tracking.
The fund has invested $500K so far; Ambient Clinical Analytics is the latest recipient.
OmniTier says its new tech platform has big implications for the spread of personalized medicine.
Capital from Urotronic's biggest funding round yet will help advance its work on a drug-coated medical balloon meant to provide a safer treatment for urethra blockages.
The Center and Connective Link will be added to the Austin campus as part of a regional goal of improved offerings and system-wide inpatient services transition.
The platform allows health researchers to bring zebrafish embryos to life after freezing.
A new 13-member research team will analyze the relationship between gut bacteria and colon cancer.
Sansoro will use the new capital – contributed by existing investors and lead investor of the round LRVHealth – to grow efforts to improve data integration for electronic health records.
The health care institution also placed first on the state-specific “Best Hospital” lists in Minnesota, Arizona and Florida.
Dr. Farrugia will officially take over as the head of Mayo Clinic at the start of next year. Current president and CEO Dr. John Noseworthy, in the meantime, will be preparing him for the role.
The Minneapolis-based startup will use the National Institute of Mental Health grant toward further development of its wearable device that treats impulsive behaviors.
Nothing has been confirmed yet, but a report from Axios indicates the Minnesota-based insurance giant will buy Washington-based pharmacy company Genoa Health.
The National Science Foundation sees commercialization potential in the University of Minnesota’s “synthetic incompatibility” process that can target certain mosquito populations.
The Minneapolis startup has raised $240 million and keeps growing.